Progression-Free Survival and Overall Survival of CDK 4/6 Inhibitors Plus Endocrine Therapy in Metastatic Breast Cancer: A Systematic Review and Meta-Analysis.
Int J Mol Sci. 2020 Sep 3;21(17):6400. doi: 10.3390/ijms21176400.
Int J Mol Sci. 2020.
PMID: 32899139
Free PMC article.